Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Astrazeneca Pharma India Ltd (ASTRAZEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH114902FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, formoterol inhalation powder and Seloken. AstraZeneca offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, oncology,renal, inflammation, autoimmunity, infection, and gastrointestinal. The company operates in China, India, Singapore, Indonesia, Australia, Malaysia, the US, and the UK. AstraZeneca is headquartered in Bengaluru, Karnataka, India.

Astrazeneca Pharma India Ltd Key Recent Developments

Mar 24,2021: Banaras Hindu University signs MoU with Indian Cancer Society for Ganga Godavari Cancer Screening Programme
Nov 26,2020: AstraZeneca’s signs MoU with Indian Diabetes Research Society (RSSDI) to empower 1 Crore Indian Diabetic patients by 2023
Aug 12,2020: AstraZeneca Pharma : Appointment of Directors at Annual General Meeting held on August 10, 2020
May 19,2020: AstraZeneca Pharma: Change in Directorate

This comprehensive SWOT profile of Astrazeneca Pharma India Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Astrazeneca Pharma India Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Astrazeneca Pharma India Ltd – Key Information
Astrazeneca Pharma India Ltd – Overview
Astrazeneca Pharma India Ltd – Key Employees
Astrazeneca Pharma India Ltd – Key Employee Biographies
Astrazeneca Pharma India Ltd – Key Operational Heads
Astrazeneca Pharma India Ltd – Major Products and Services
Astrazeneca Pharma India Ltd – History
Astrazeneca Pharma India Ltd – Company Statement
Astrazeneca Pharma India Ltd – Locations And Subsidiaries
Astrazeneca Pharma India Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Astrazeneca Pharma India Ltd – Business Description
Astrazeneca Pharma India Ltd – Corporate Strategy
Astrazeneca Pharma India Ltd – SWOT Analysis
SWOT Analysis – Overview
Astrazeneca Pharma India Ltd – Strengths
Astrazeneca Pharma India Ltd – Weaknesses
Astrazeneca Pharma India Ltd – Opportunities
Astrazeneca Pharma India Ltd – Threats
Astrazeneca Pharma India Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Astrazeneca Pharma India Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Astrazeneca Pharma India Ltd, Key Information
Astrazeneca Pharma India Ltd, Key Ratios
Astrazeneca Pharma India Ltd, Share Data
Astrazeneca Pharma India Ltd, Major Products and Services
Astrazeneca Pharma India Ltd, History
Astrazeneca Pharma India Ltd, Key Employees
Astrazeneca Pharma India Ltd, Key Employee Biographies
Astrazeneca Pharma India Ltd, Key Operational Heads
Astrazeneca Pharma India Ltd, Other Locations
Astrazeneca Pharma India Ltd, Subsidiaries
Astrazeneca Pharma India Ltd, Key Competitors
Astrazeneca Pharma India Ltd, SWOT Analysis
Astrazeneca Pharma India Ltd, Ratios based on current share price
Astrazeneca Pharma India Ltd, Annual Ratios
Astrazeneca Pharma India Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bolu Cimento Sanayii AS:企業の戦略・SWOT・財務情報
    Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report Summary Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Harman International Industries, Incorporated:企業のM&A・事業提携・投資動向
    Harman International Industries, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harman International Industries, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Sanofi Genzyme:企業の戦略・SWOT・財務分析
    Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report Summary Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Osaka Gas Co Ltd (9532):石油・ガス:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • Kitov Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kitov Pharmaceuticals Ltd (Kitov Pharmaceuticals) a subsidiary of Kitov Pharma Ltd, is a biopharmaceutical company with focus on drug development. Its pipeline therapeutic candidates include Consensi, a combination drug with celecoxib and amlodipine besylate as active ingredients for the tre …
  • HepQuant Llc:企業の製品パイプライン分析2018
    Summary Hepquant LLC (Hepquant) is a medical device company that offers diagnostic products. The company develops and markets patented and patent-pending technology for assessing liver function of patients with chronic liver disease. It offers investigational combination drug and diagnostic devices. …
  • Battalion Oil Corp (HKRSQ):企業の財務・戦略的SWOT分析
    Summary Battalion Oil Corp (Battalion Oil), formerly Halcon Resources Corp, is an independent energy company that carries out the acquisition, production, exploration and development of onshore oil and natural gas properties. Battalion Oil mainly focuses on the Delaware Basin, East Texas. The compan …
  • Telus Corp (T):企業の財務・戦略的SWOT分析
    Telus Corp (T) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Pakistan Refinery Ltd (PRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pakistan Refinery Ltd (PRL) is a downstream oil and gas company. It carries out refining, production and supply of refined petroleum products. It operates a hydro skimming refinery, which is designed to process various imported and local crude oil into distilled petroleum products such as fu …
  • Nynas AB:企業の戦略的SWOT分析
    Nynas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Golden Valley Mines Ltd. (GZZ):企業の財務・戦略的SWOT分析
    Golden Valley Mines Ltd. (GZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NeoGenomics Inc (NEO):医療機器:M&Aディール及び事業提携情報
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Meyer Burger Technology AG (MBTN)-エネルギー分野:企業M&A・提携分析
    Summary Meyer Burger Technology AG (Meyer Burger) is a technology company that provides technology, systems, machinery and processes for cutting and handling crystalline and other high-grade materials. It supplies ultra-thin wafers made from silicon, sapphire or other crystals for the manufacture of …
  • Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomp …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Horizon Therapeutics PLC (HZNP):企業の財務・戦略的SWOT分析
    Horizon Therapeutics PLC (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Diversicare Healthcare Services Inc (DVCR):企業の財務・戦略的SWOT分析
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆